Concepedia
Statistics
Publications
12
Citations
390
H-Index
Active since
2019
Affiliations
University of California, Los Angeles(Current)
First Affiliated Hospital of Zhengzhou University
Chulabhorn Hospital
University of California System
Peking University People's Hospital
Dylan C. Dean is an author at University of California, Los Angeles specializing in oncology, molecular oncology, and medicine.
Publications per year
2019–2021
Role of cyclin‐dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway
Shen Shen, Dylan C. Dean, Zujiang Yu · Hepatology Research · 2019 · 64 citations
Medicine, Cancer Biology, Oncology +17
Cyclin‐dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer
Jinglu Wang, Dylan C. Dean, Francis J. Hornicek et al. · The FASEB Journal · 2019 · 63 citations · Full text
Medicine, Gynecology, Oncology +16
RETRACTED: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
Wenlong Feng, Dylan C. Dean, Francis J. Hornicek et al. · Therapeutic Advances in Medical Oncology · 2020 · 56 citations · Full text
Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma
Ran Wei, Pichaya Thanindratarn, Dylan C. Dean et al. · Journal of Orthopaedic Research® · 2020 · 31 citations · Full text
Medicine, Molecular Biology, Oncology +17
Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma
Juncheng Cui, Dylan C. Dean, Ran Wei et al. · Journal of Orthopaedic Research® · 2020 · 30 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
1–5 of 12